Ekso Bionics Holdings

EKSO

US2826444000

Market Closed - Nasdaq 04:00:00 2026-10-09 pm EDT			5-day change	1st Jan Change
18.59 ^USD	-2.31%		+0.20%	+115.16%

May. 05	Applied Digital Cloud Corporation completed the acquisition of Ekso Bionics Holdings, Inc. in a reverse merger transaction.	CI
May. 05	Applied Digital completes separation of cloud business, establishing Chronoscale as independent public company	RE

Top Premarket Decliners

Published on 12/31/2025 at 08:09 am EST

MT Newswires

This article is reserved for our members.

Continue with Google Continue with Apple Continue with LinkedIn

or by email

Continue with an email.

Latest news about Ekso Bionics Holdings

May. 05	Applied Digital Cloud Corporation completed the acquisition of Ekso Bionics Holdings, Inc. in a reverse merger transaction.	CI
May. 05	Applied Digital completes separation of cloud business, establishing Chronoscale as independent public company	RE
May. 04	Ekso Bionics Holdings, Inc.(NasdaqCM:CHRN) dropped from NASDAQ Composite Index	CI
Apr. 28	Ekso Bionics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Feb. 23	Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Feb. 22	Ekso Bionics Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
Feb. 17	Ekso Bionics Holdings Insider Bought Shares Worth $970,069, According to a Recent SEC Filing	MT
Feb. 17	Ekso Bionics Holdings on Feb 15, enters agreement with Apld Intermediate	RE
Feb. 17	Ekso Bionics Holdings, Inc. Provides Earnings Guidance for the Fourth Quarter 2025	CI
Jan. 21	Ekso Bionics Holdings, Inc. announced that it has received $5.852 million in funding	CI
Jan. 19	Ekso Bionics Holdings, Inc. announced that it expects to receive $5.852 million in funding	CI
Jan. 07	Applied Digital beats quarterly revenue estimates on AI data center demand, shares jump	RE
Dec. 31	Equity Futures Edge Higher Premarket Wednesday After Better-Than-Expected Jobless Claims Report	MT
Dec. 31	Top Premarket Decliners	MT
Dec. 30	US Equity Indexes Lower After FOMC Minutes Reveal Support for Keeping Rates Unchanged	MT

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.

Employees

Sector

More about the company